BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: An Y, Wang Y, Wu S, Wang YH, Qian X, Li Z, Fu YJ, Xie Y. Fourth-generation quinolones in the treatment of Helicobacter pylori infection: A meta-analysis. World J Gastroenterol 2018; 24(29): 3302-3312 [PMID: 30090010 DOI: 10.3748/wjg.v24.i29.3302]
URL: https://www.wjgnet.com/1007-9327/full/v24/i29/3302.htm
Number Citing Articles
Diego Burgos‐Santamaría, Adrian G. McNicholl, Javier P. Gisbert. Empirical Helicobacter pylori rescue therapy: an 18‐year single‐centre study of 1200 patients GastroHep 2019; 1(6): 311 doi: 10.1002/ygh2.372
Peter Malfertheiner, M. Constanza Camargo, Emad El-Omar, Jyh-Ming Liou, Richard Peek, Christian Schulz, Stella I. Smith, Sebastian Suerbaum. Helicobacter pylori infectionNature Reviews Disease Primers 2023; 9(1) doi: 10.1038/s41572-023-00431-8
Hiroshi Matsumoto, Akiko Shiotani, David Y. Graham. Helicobacter pylori in Human DiseasesAdvances in Experimental Medicine and Biology 2019; 1149: 211 doi: 10.1007/5584_2019_367
Youn I Choi, Sung Min Lee, Jun-Won Chung, Kyoung Oh Kim, Kwang An Kwon, Yoon Jae Kim, Jung Ho Kim, Sun Mi Lee, Jin-Yong Jeong, Dong Kyun Park. Therapeutic Potential of Sitafloxacin as a New Drug Candidate for Helicobacter Eradication in Korea: An In Vitro Culture-Based StudyAntibiotics 2021; 10(10): 1242 doi: 10.3390/antibiotics10101242
Najmeh Salehi, Bahareh Attaran, Negin Eskini, Maryam Esmaeili, Atefeh Sharifirad, Mehdi Sadeghi, Marjan Mohammadi. New insights into resistance ofHelicobacter pyloriagainst third‐ and fourth‐generation fluoroquinolones: A molecular docking study of prevalent GyrA mutationsHelicobacter 2019; 24(5) doi: 10.1111/hel.12628